These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Investigation of a combination therapy approach for the treatment of melioidosis. Barnes KB; Richards MI; Burgess G; Armstrong SJ; Bentley C; Maishman TC; Laws TR; Nelson M; Harding SV Front Microbiol; 2022; 13():934312. PubMed ID: 36051754 [TBL] [Abstract][Full Text] [Related]
6. Pre- and post-exposure prophylaxis of experimental Burkholderia pseudomallei infection with doxycycline, amoxicillin/clavulanic acid and co-trimoxazole. Sivalingam SP; Sim SH; Jasper LC; Wang D; Liu Y; Ooi EE J Antimicrob Chemother; 2008 Mar; 61(3):674-8. PubMed ID: 18192684 [TBL] [Abstract][Full Text] [Related]
7. The BALB/c Mouse Model for the Evaluation of Therapies to Treat Infections with Aerosolized Nelson M; Barnes KB; Davies CH; Cote CK; Meinig JM; Biryukov SS; Dyer DN; Frick O; Heine H; Pfefferle DA; Horstman-Smith A; Barbaras J; Harding SV Antibiotics (Basel); 2023 Mar; 12(3):. PubMed ID: 36978372 [No Abstract] [Full Text] [Related]
8. Potential of repurposing chloroquine as an adjunct therapy for melioidosis based on a murine model of Burkholderia pseudomallei infection. Ganesan N; Embi N; Hasidah MS Trop Biomed; 2020 Jun; 37(2):303-317. PubMed ID: 33612800 [TBL] [Abstract][Full Text] [Related]
9. Mechanisms of Resistance to Folate Pathway Inhibitors in Podnecky NL; Rhodes KA; Mima T; Drew HR; Chirakul S; Wuthiekanun V; Schupp JM; Sarovich DS; Currie BJ; Keim P; Schweizer HP mBio; 2017 Sep; 8(5):. PubMed ID: 28874476 [TBL] [Abstract][Full Text] [Related]
10. Particle-size dependent effects in the Balb/c murine model of inhalational melioidosis. Thomas RJ; Davies C; Nunez A; Hibbs S; Eastaugh L; Harding S; Jordan J; Barnes K; Oyston P; Eley S Front Cell Infect Microbiol; 2012; 2():101. PubMed ID: 22919690 [TBL] [Abstract][Full Text] [Related]
11. Dose-dependant acute or subacute disease caused by Burkholderia pseudomallei strain NCTC 13392 in a BALB/c aerosol model of infection. Funnell SGP; Tree JA; Hatch GJ; Bate SR; Hall G; Pearson G; Rayner EL; Roberts ADG; Vipond J J Appl Microbiol; 2019 Oct; 127(4):1224-1235. PubMed ID: 31330088 [TBL] [Abstract][Full Text] [Related]
12. Experimental Persistent Infection of BALB/c Mice with Small-Colony Variants of Burkholderia pseudomallei Leads to Concurrent Upregulation of PD-1 on T Cells and Skewed Th1 and Th17 Responses. See JX; Samudi C; Saeidi A; Menon N; Choh LC; Vadivelu J; Shankar EM PLoS Negl Trop Dis; 2016 Mar; 10(3):e0004503. PubMed ID: 26974441 [TBL] [Abstract][Full Text] [Related]
13. Activity of tigecycline in the treatment of acute Burkholderia pseudomallei infection in a murine model. Feterl M; Govan B; Engler C; Norton R; Ketheesan N Int J Antimicrob Agents; 2006 Nov; 28(5):460-4. PubMed ID: 17046208 [TBL] [Abstract][Full Text] [Related]
14. Characterization of pathogenesis of and immune response to Burkholderia pseudomallei K96243 using both inhalational and intraperitoneal infection models in BALB/c and C57BL/6 mice. Bearss JJ; Hunter M; Dankmeyer JL; Fritts KA; Klimko CP; Weaver CH; Shoe JL; Quirk AV; Toothman RG; Webster WM; Fetterer DP; Bozue JA; Worsham PL; Welkos SL; Amemiya K; Cote CK PLoS One; 2017; 12(2):e0172627. PubMed ID: 28235018 [TBL] [Abstract][Full Text] [Related]
15. Multicomponent Gold-Linked Glycoconjugate Vaccine Elicits Antigen-Specific Humoral and Mixed T Tapia D; Sanchez-Villamil JI; Stevenson HL; Torres AG mBio; 2021 Jun; 12(3):e0122721. PubMed ID: 34182777 [TBL] [Abstract][Full Text] [Related]
16. Within-Host Evolution of Viberg LT; Sarovich DS; Kidd TJ; Geake JB; Bell SC; Currie BJ; Price EP mBio; 2017 Apr; 8(2):. PubMed ID: 28400528 [TBL] [Abstract][Full Text] [Related]
17. BALB/c and C57Bl/6 mice infected with virulent Burkholderia pseudomallei provide contrasting animal models for the acute and chronic forms of human melioidosis. Leakey AK; Ulett GC; Hirst RG Microb Pathog; 1998 May; 24(5):269-75. PubMed ID: 9600859 [TBL] [Abstract][Full Text] [Related]
18. Experimental acute respiratory Burkholderia pseudomallei infection in BALB/c mice. Lever MS; Nelson M; Stagg AJ; Beedham RJ; Simpson AJ Int J Exp Pathol; 2009 Feb; 90(1):16-25. PubMed ID: 19200247 [TBL] [Abstract][Full Text] [Related]
19. A comparison of antibiotic regimens in the treatment of acute melioidosis in a mouse model. Ulett GC; Hirst R; Bowden B; Powell K; Norton R J Antimicrob Chemother; 2003 Jan; 51(1):77-81. PubMed ID: 12493790 [TBL] [Abstract][Full Text] [Related]
20. Use of a safe, reproducible, and rapid aerosol delivery method to study infection by Burkholderia pseudomallei and Burkholderia mallei in mice. Lafontaine ER; Zimmerman SM; Shaffer TL; Michel F; Gao X; Hogan RJ PLoS One; 2013; 8(10):e76804. PubMed ID: 24098563 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]